Cargando…
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
PURPOSE: Advanced-stage mucinous ovarian carcinoma (MOC) has poor chemotherapy response and prognosis and lacks biomarkers to aid stage I adjuvant treatment. Differentiating primary MOC from gastrointestinal (GI) metastases to the ovary is also challenging due to phenotypic similarities. Clinicopath...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751776/ https://www.ncbi.nlm.nih.gov/pubmed/36222710 http://dx.doi.org/10.1158/1078-0432.CCR-22-1206 |
_version_ | 1784850555238088704 |
---|---|
author | Meagher, Nicola S. Gorringe, Kylie L. Wakefield, Matthew Bolithon, Adelyn Pang, Chi Nam Ignatius Chiu, Derek S. Anglesio, Michael S. Mallitt, Kylie-Ann Doherty, Jennifer A. Harris, Holly R. Schildkraut, Joellen M. Berchuck, Andrew Cushing-Haugen, Kara L. Chezar, Ksenia Chou, Angela Tan, Adeline Alsop, Jennifer Barlow, Ellen Beckmann, Matthias W. Boros, Jessica Bowtell, David D.L. Brand, Alison H. Brenton, James D. Campbell, Ian Cheasley, Dane Cohen, Joshua Cybulski, Cezary Elishaev, Esther Erber, Ramona Farrell, Rhonda Fischer, Anna Fu, Zhuxuan Gilks, Blake Gill, Anthony J. Gourley, Charlie Grube, Marcel Harnett, Paul R. Hartmann, Arndt Hettiaratchi, Anusha Høgdall, Claus K. Huzarski, Tomasz Jakubowska, Anna Jimenez-Linan, Mercedes Kennedy, Catherine J. Kim, Byoung-Gie Kim, Jae-Weon Kim, Jae-Hoon Klett, Kayla Koziak, Jennifer M. Lai, Tiffany Laslavic, Angela Lester, Jenny Leung, Yee Li, Na Liauw, Winston Lim, Belle W.X. Linder, Anna Lubiński, Jan Mahale, Sakshi Mateoiu, Constantina McInerny, Simone Menkiszak, Janusz Minoo, Parham Mittelstadt, Suzana Morris, David Orsulic, Sandra Park, Sang-Yoon Pearce, Celeste Leigh Pearson, John V. Pike, Malcolm C. Quinn, Carmel M. Mohan, Ganendra Raj Rao, Jianyu Riggan, Marjorie J. Ruebner, Matthias Salfinger, Stuart Scott, Clare L. Shah, Mitul Steed, Helen Stewart, Colin J.R. Subramanian, Deepak Sung, Soseul Tang, Katrina Timpson, Paul Ward, Robyn L. Wiedenhoefer, Rebekka Thorne, Heather Cohen, Paul A. Crowe, Philip Fasching, Peter A. Gronwald, Jacek Hawkins, Nicholas J. Høgdall, Estrid Huntsman, David G. James, Paul A. Karlan, Beth Y. Kelemen, Linda E. Kommoss, Stefan Konecny, Gottfried E. Modugno, Francesmary Park, Sue K. Staebler, Annette Sundfeldt, Karin Wu, Anna H. Talhouk, Aline Pharoah, Paul D.P. Anderson, Lyndal DeFazio, Anna Köbel, Martin Friedlander, Michael L. Ramus, Susan J. |
author_facet | Meagher, Nicola S. Gorringe, Kylie L. Wakefield, Matthew Bolithon, Adelyn Pang, Chi Nam Ignatius Chiu, Derek S. Anglesio, Michael S. Mallitt, Kylie-Ann Doherty, Jennifer A. Harris, Holly R. Schildkraut, Joellen M. Berchuck, Andrew Cushing-Haugen, Kara L. Chezar, Ksenia Chou, Angela Tan, Adeline Alsop, Jennifer Barlow, Ellen Beckmann, Matthias W. Boros, Jessica Bowtell, David D.L. Brand, Alison H. Brenton, James D. Campbell, Ian Cheasley, Dane Cohen, Joshua Cybulski, Cezary Elishaev, Esther Erber, Ramona Farrell, Rhonda Fischer, Anna Fu, Zhuxuan Gilks, Blake Gill, Anthony J. Gourley, Charlie Grube, Marcel Harnett, Paul R. Hartmann, Arndt Hettiaratchi, Anusha Høgdall, Claus K. Huzarski, Tomasz Jakubowska, Anna Jimenez-Linan, Mercedes Kennedy, Catherine J. Kim, Byoung-Gie Kim, Jae-Weon Kim, Jae-Hoon Klett, Kayla Koziak, Jennifer M. Lai, Tiffany Laslavic, Angela Lester, Jenny Leung, Yee Li, Na Liauw, Winston Lim, Belle W.X. Linder, Anna Lubiński, Jan Mahale, Sakshi Mateoiu, Constantina McInerny, Simone Menkiszak, Janusz Minoo, Parham Mittelstadt, Suzana Morris, David Orsulic, Sandra Park, Sang-Yoon Pearce, Celeste Leigh Pearson, John V. Pike, Malcolm C. Quinn, Carmel M. Mohan, Ganendra Raj Rao, Jianyu Riggan, Marjorie J. Ruebner, Matthias Salfinger, Stuart Scott, Clare L. Shah, Mitul Steed, Helen Stewart, Colin J.R. Subramanian, Deepak Sung, Soseul Tang, Katrina Timpson, Paul Ward, Robyn L. Wiedenhoefer, Rebekka Thorne, Heather Cohen, Paul A. Crowe, Philip Fasching, Peter A. Gronwald, Jacek Hawkins, Nicholas J. Høgdall, Estrid Huntsman, David G. James, Paul A. Karlan, Beth Y. Kelemen, Linda E. Kommoss, Stefan Konecny, Gottfried E. Modugno, Francesmary Park, Sue K. Staebler, Annette Sundfeldt, Karin Wu, Anna H. Talhouk, Aline Pharoah, Paul D.P. Anderson, Lyndal DeFazio, Anna Köbel, Martin Friedlander, Michael L. Ramus, Susan J. |
author_sort | Meagher, Nicola S. |
collection | PubMed |
description | PURPOSE: Advanced-stage mucinous ovarian carcinoma (MOC) has poor chemotherapy response and prognosis and lacks biomarkers to aid stage I adjuvant treatment. Differentiating primary MOC from gastrointestinal (GI) metastases to the ovary is also challenging due to phenotypic similarities. Clinicopathologic and gene-expression data were analyzed to identify prognostic and diagnostic features. EXPERIMENTAL DESIGN: Discovery analyses selected 19 genes with prognostic/diagnostic potential. Validation was performed through the Ovarian Tumor Tissue Analysis consortium and GI cancer biobanks comprising 604 patients with MOC (n = 333), mucinous borderline ovarian tumors (MBOT, n = 151), and upper GI (n = 65) and lower GI tumors (n = 55). RESULTS: Infiltrative pattern of invasion was associated with decreased overall survival (OS) within 2 years from diagnosis, compared with expansile pattern in stage I MOC [hazard ratio (HR), 2.77; 95% confidence interval (CI), 1.04–7.41, P = 0.042]. Increased expression of THBS2 and TAGLN was associated with shorter OS in MOC patients (HR, 1.25; 95% CI, 1.04–1.51, P = 0.016) and (HR, 1.21; 95% CI, 1.01–1.45, P = 0.043), respectively. ERBB2 (HER2) amplification or high mRNA expression was evident in 64 of 243 (26%) of MOCs, but only 8 of 243 (3%) were also infiltrative (4/39, 10%) or stage III/IV (4/31, 13%). CONCLUSIONS: An infiltrative growth pattern infers poor prognosis within 2 years from diagnosis and may help select stage I patients for adjuvant therapy. High expression of THBS2 and TAGLN in MOC confers an adverse prognosis and is upregulated in the infiltrative subtype, which warrants further investigation. Anti-HER2 therapy should be investigated in a subset of patients. MOC samples clustered with upper GI, yet markers to differentiate these entities remain elusive, suggesting similar underlying biology and shared treatment strategies. |
format | Online Article Text |
id | pubmed-9751776 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Association for Cancer Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-97517762023-01-05 Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes Meagher, Nicola S. Gorringe, Kylie L. Wakefield, Matthew Bolithon, Adelyn Pang, Chi Nam Ignatius Chiu, Derek S. Anglesio, Michael S. Mallitt, Kylie-Ann Doherty, Jennifer A. Harris, Holly R. Schildkraut, Joellen M. Berchuck, Andrew Cushing-Haugen, Kara L. Chezar, Ksenia Chou, Angela Tan, Adeline Alsop, Jennifer Barlow, Ellen Beckmann, Matthias W. Boros, Jessica Bowtell, David D.L. Brand, Alison H. Brenton, James D. Campbell, Ian Cheasley, Dane Cohen, Joshua Cybulski, Cezary Elishaev, Esther Erber, Ramona Farrell, Rhonda Fischer, Anna Fu, Zhuxuan Gilks, Blake Gill, Anthony J. Gourley, Charlie Grube, Marcel Harnett, Paul R. Hartmann, Arndt Hettiaratchi, Anusha Høgdall, Claus K. Huzarski, Tomasz Jakubowska, Anna Jimenez-Linan, Mercedes Kennedy, Catherine J. Kim, Byoung-Gie Kim, Jae-Weon Kim, Jae-Hoon Klett, Kayla Koziak, Jennifer M. Lai, Tiffany Laslavic, Angela Lester, Jenny Leung, Yee Li, Na Liauw, Winston Lim, Belle W.X. Linder, Anna Lubiński, Jan Mahale, Sakshi Mateoiu, Constantina McInerny, Simone Menkiszak, Janusz Minoo, Parham Mittelstadt, Suzana Morris, David Orsulic, Sandra Park, Sang-Yoon Pearce, Celeste Leigh Pearson, John V. Pike, Malcolm C. Quinn, Carmel M. Mohan, Ganendra Raj Rao, Jianyu Riggan, Marjorie J. Ruebner, Matthias Salfinger, Stuart Scott, Clare L. Shah, Mitul Steed, Helen Stewart, Colin J.R. Subramanian, Deepak Sung, Soseul Tang, Katrina Timpson, Paul Ward, Robyn L. Wiedenhoefer, Rebekka Thorne, Heather Cohen, Paul A. Crowe, Philip Fasching, Peter A. Gronwald, Jacek Hawkins, Nicholas J. Høgdall, Estrid Huntsman, David G. James, Paul A. Karlan, Beth Y. Kelemen, Linda E. Kommoss, Stefan Konecny, Gottfried E. Modugno, Francesmary Park, Sue K. Staebler, Annette Sundfeldt, Karin Wu, Anna H. Talhouk, Aline Pharoah, Paul D.P. Anderson, Lyndal DeFazio, Anna Köbel, Martin Friedlander, Michael L. Ramus, Susan J. Clin Cancer Res Precision Medicine and Imaging PURPOSE: Advanced-stage mucinous ovarian carcinoma (MOC) has poor chemotherapy response and prognosis and lacks biomarkers to aid stage I adjuvant treatment. Differentiating primary MOC from gastrointestinal (GI) metastases to the ovary is also challenging due to phenotypic similarities. Clinicopathologic and gene-expression data were analyzed to identify prognostic and diagnostic features. EXPERIMENTAL DESIGN: Discovery analyses selected 19 genes with prognostic/diagnostic potential. Validation was performed through the Ovarian Tumor Tissue Analysis consortium and GI cancer biobanks comprising 604 patients with MOC (n = 333), mucinous borderline ovarian tumors (MBOT, n = 151), and upper GI (n = 65) and lower GI tumors (n = 55). RESULTS: Infiltrative pattern of invasion was associated with decreased overall survival (OS) within 2 years from diagnosis, compared with expansile pattern in stage I MOC [hazard ratio (HR), 2.77; 95% confidence interval (CI), 1.04–7.41, P = 0.042]. Increased expression of THBS2 and TAGLN was associated with shorter OS in MOC patients (HR, 1.25; 95% CI, 1.04–1.51, P = 0.016) and (HR, 1.21; 95% CI, 1.01–1.45, P = 0.043), respectively. ERBB2 (HER2) amplification or high mRNA expression was evident in 64 of 243 (26%) of MOCs, but only 8 of 243 (3%) were also infiltrative (4/39, 10%) or stage III/IV (4/31, 13%). CONCLUSIONS: An infiltrative growth pattern infers poor prognosis within 2 years from diagnosis and may help select stage I patients for adjuvant therapy. High expression of THBS2 and TAGLN in MOC confers an adverse prognosis and is upregulated in the infiltrative subtype, which warrants further investigation. Anti-HER2 therapy should be investigated in a subset of patients. MOC samples clustered with upper GI, yet markers to differentiate these entities remain elusive, suggesting similar underlying biology and shared treatment strategies. American Association for Cancer Research 2022-12-15 2022-10-07 /pmc/articles/PMC9751776/ /pubmed/36222710 http://dx.doi.org/10.1158/1078-0432.CCR-22-1206 Text en ©2022 The Authors; Published by the American Association for Cancer Research https://creativecommons.org/licenses/by/4.0/This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. |
spellingShingle | Precision Medicine and Imaging Meagher, Nicola S. Gorringe, Kylie L. Wakefield, Matthew Bolithon, Adelyn Pang, Chi Nam Ignatius Chiu, Derek S. Anglesio, Michael S. Mallitt, Kylie-Ann Doherty, Jennifer A. Harris, Holly R. Schildkraut, Joellen M. Berchuck, Andrew Cushing-Haugen, Kara L. Chezar, Ksenia Chou, Angela Tan, Adeline Alsop, Jennifer Barlow, Ellen Beckmann, Matthias W. Boros, Jessica Bowtell, David D.L. Brand, Alison H. Brenton, James D. Campbell, Ian Cheasley, Dane Cohen, Joshua Cybulski, Cezary Elishaev, Esther Erber, Ramona Farrell, Rhonda Fischer, Anna Fu, Zhuxuan Gilks, Blake Gill, Anthony J. Gourley, Charlie Grube, Marcel Harnett, Paul R. Hartmann, Arndt Hettiaratchi, Anusha Høgdall, Claus K. Huzarski, Tomasz Jakubowska, Anna Jimenez-Linan, Mercedes Kennedy, Catherine J. Kim, Byoung-Gie Kim, Jae-Weon Kim, Jae-Hoon Klett, Kayla Koziak, Jennifer M. Lai, Tiffany Laslavic, Angela Lester, Jenny Leung, Yee Li, Na Liauw, Winston Lim, Belle W.X. Linder, Anna Lubiński, Jan Mahale, Sakshi Mateoiu, Constantina McInerny, Simone Menkiszak, Janusz Minoo, Parham Mittelstadt, Suzana Morris, David Orsulic, Sandra Park, Sang-Yoon Pearce, Celeste Leigh Pearson, John V. Pike, Malcolm C. Quinn, Carmel M. Mohan, Ganendra Raj Rao, Jianyu Riggan, Marjorie J. Ruebner, Matthias Salfinger, Stuart Scott, Clare L. Shah, Mitul Steed, Helen Stewart, Colin J.R. Subramanian, Deepak Sung, Soseul Tang, Katrina Timpson, Paul Ward, Robyn L. Wiedenhoefer, Rebekka Thorne, Heather Cohen, Paul A. Crowe, Philip Fasching, Peter A. Gronwald, Jacek Hawkins, Nicholas J. Høgdall, Estrid Huntsman, David G. James, Paul A. Karlan, Beth Y. Kelemen, Linda E. Kommoss, Stefan Konecny, Gottfried E. Modugno, Francesmary Park, Sue K. Staebler, Annette Sundfeldt, Karin Wu, Anna H. Talhouk, Aline Pharoah, Paul D.P. Anderson, Lyndal DeFazio, Anna Köbel, Martin Friedlander, Michael L. Ramus, Susan J. Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes |
title | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes |
title_full | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes |
title_fullStr | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes |
title_full_unstemmed | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes |
title_short | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes |
title_sort | gene-expression profiling of mucinous ovarian tumors and comparison with upper and lower gastrointestinal tumors identifies markers associated with adverse outcomes |
topic | Precision Medicine and Imaging |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751776/ https://www.ncbi.nlm.nih.gov/pubmed/36222710 http://dx.doi.org/10.1158/1078-0432.CCR-22-1206 |
work_keys_str_mv | AT meaghernicolas geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT gorringekyliel geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT wakefieldmatthew geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT bolithonadelyn geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT pangchinamignatius geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT chiudereks geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT anglesiomichaels geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT mallittkylieann geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT dohertyjennifera geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT harrishollyr geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT schildkrautjoellenm geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT berchuckandrew geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT cushinghaugenkaral geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT chezarksenia geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT chouangela geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT tanadeline geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT alsopjennifer geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT barlowellen geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT beckmannmatthiasw geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT borosjessica geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT bowtelldaviddl geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT brandalisonh geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT brentonjamesd geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT campbellian geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT cheasleydane geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT cohenjoshua geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT cybulskicezary geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT elishaevesther geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT erberramona geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT farrellrhonda geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT fischeranna geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT fuzhuxuan geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT gilksblake geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT gillanthonyj geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT gourleycharlie geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT grubemarcel geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT harnettpaulr geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT hartmannarndt geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT hettiaratchianusha geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT høgdallclausk geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT huzarskitomasz geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT jakubowskaanna geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT jimenezlinanmercedes geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT kennedycatherinej geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT kimbyounggie geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT kimjaeweon geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT kimjaehoon geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT klettkayla geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT koziakjenniferm geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT laitiffany geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT laslavicangela geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT lesterjenny geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT leungyee geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT lina geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT liauwwinston geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT limbellewx geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT linderanna geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT lubinskijan geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT mahalesakshi geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT mateoiuconstantina geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT mcinernysimone geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT menkiszakjanusz geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT minooparham geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT mittelstadtsuzana geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT morrisdavid geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT orsulicsandra geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT parksangyoon geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT pearcecelesteleigh geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT pearsonjohnv geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT pikemalcolmc geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT quinncarmelm geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT mohanganendraraj geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT raojianyu geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT rigganmarjoriej geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT ruebnermatthias geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT salfingerstuart geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT scottclarel geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT shahmitul geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT steedhelen geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT stewartcolinjr geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT subramaniandeepak geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT sungsoseul geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT tangkatrina geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT timpsonpaul geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT wardrobynl geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT wiedenhoeferrebekka geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT thorneheather geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT cohenpaula geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT crowephilip geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT faschingpetera geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT gronwaldjacek geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT hawkinsnicholasj geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT høgdallestrid geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT huntsmandavidg geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT jamespaula geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT karlanbethy geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT kelemenlindae geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT kommossstefan geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT konecnygottfriede geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT modugnofrancesmary geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT parksuek geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT staeblerannette geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT sundfeldtkarin geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT wuannah geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT talhoukaline geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT pharoahpauldp geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT andersonlyndal geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT defazioanna geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT kobelmartin geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT friedlandermichaell geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes AT ramussusanj geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes |